The Study of Delay Discounting Among Beneficiaries of the Pé-de-Meia Program

The Study of Delay Discounting Propensity Among Beneficiaries of the Pé-de-Meia Program: The High School Savings Plan

The aim of this observational study is to explore how the "Pé-de-Meia" Program, a policy of the Brazilian Federal Government designed to encourage the retention and completion of studies by students from low-income families, affects both the students' tendency towards delay discounting and their academic performance. The study seeks to answer the following questions:

How does the "Pé-de-Meia" Program affect the students' propensity for delay discounting? Is there a relationship between the level of delay discounting among students, their academic performance, and school attendance? Participants in the study, high school students enrolled in the "Pé-de-Meia" Program, will undergo assessments to measure their level of delay discounting. The academic performance and school attendance of the participants will be monitored and analyzed in relation to their propensity for delay discounting

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Youth between 14 and 24 years of age, duly enrolled in public education institutions and belonging to families that benefit from the Bolsa Família Program.

Description

Inclusion Criteria:

High school students, Students from public schools; Students from low-income families. -

Exclusion Criteria:

Students with a formal psychological report; students with a formal psychiatric report.

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participants of the Pé-de-Meia Program

The "Pé-de-Meia" Program was established by the Brazilian Federal Government with the aim of encouraging the retention of low-income students in high school by providing maintenance scholarships and savings opportunities. To be eligible for the program, a young person must: Be properly enrolled in a regular public high school course, be between 14 to 24 years old, come from a low-income family, and be registered in the Bolsa Família Program. The Program offers four types of incentives:

An enrollment grant registered at the beginning of the academic year, paid once a year in the amount of 200 BRL.

A minimum school attendance of 80% of the total class hours, paid in nine installments throughout the year at 200 BRL each.

Proven participation in the National High School Exam (ENEM), paid once to the student enrolled in the third year of high school, in the amount of 200 BRL.

Completion of the high school academic years, paid in a single installment of 1,000 BRL.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delay discounting
Time Frame: April 2024, July 2024, October 2024, December 2024, February 2025, April 2025, July 2025, October 2025, December 2025

Delay discounting measured by the Monetary Choice Questionnaire (MCQ).0.0 indicates an absence of discounting, meaning the individual values immediate and future rewards equally. This can be interpreted as a preference for delayed rewards or a long-term perspective.

0.5 indicates strong discounting, meaning the individual significantly devalues future rewards in favor of immediate ones. This is seen as an indication of high impulsivity.

April 2024, July 2024, October 2024, December 2024, February 2025, April 2025, July 2025, October 2025, December 2025
Academic performance - grades
Time Frame: December 2024 and December 2025
Academic performance will be assessed based on school grades, categorized as follows: grades below 6 will indicate low performance; grades between 6 and 8 will reflect a medium performance; and grades between 8 and 10, a high performance
December 2024 and December 2025
School attendance
Time Frame: December 2024 and December 2025
School attendance will be evaluated based on the regularity of class attendance, organized into the following categories: an attendance rate below 80% will be considered low, while an attendance rate of 80% or more will indicate excellent school attendance.
December 2024 and December 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

March 15, 2024

First Submitted That Met QC Criteria

March 25, 2024

First Posted (Actual)

April 2, 2024

Study Record Updates

Last Update Posted (Actual)

April 2, 2024

Last Update Submitted That Met QC Criteria

March 25, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • obs. Delay Discounting

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I will review every request and make a decision later.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delay Discounting

Clinical Trials on Pé-de-Meia Program

Subscribe